(Q42805021)

7 November 2017

title

Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue (English)

1 reference

7 November 2017

Haiya Wu

1

1 reference

7 November 2017

Li Wei

2

1 reference

7 November 2017

Yuqian Bao

3

1 reference

7 November 2017

Junxi Lu

4

1 reference

7 November 2017

Ping Huang

5

1 reference

7 November 2017

Yong Liu

6

1 reference

7 November 2017

Weiping Jia

7

1 reference

7 November 2017

Kunsan Xiang

8

1 reference

7 November 2017

publication date

16 December 2008

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 November 2017

published in

1 reference

7 November 2017

volume

296

1 reference

7 November 2017

issue

4

1 reference

7 November 2017

page(s)

E628-34

1 reference

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Retinol-binding protein: the serum transport protein for vitamin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

An enzymatic explanation of the differential effects of oleate and gemfibrozil on cultured hepatocyte triacylglycerol and phosphatidylcholine biosynthesis and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Effect of chronic treatment with Enicostemma littorale in non-insulin-dependent diabetic (NIDDM) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

The effects of physiological and pharmacological weight loss on adiponectin and leptin mRNA levels in the rat epididymal adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90526.2008

10.1152/AJPENDO.90526.2008

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference